Genetic variants may affect breast cancer drug concentrations and patient outcomes
In a study of 110 women taking the breast cancer drug anastrozole, there were significant differences in patients' blood levels of the drug that corresponded with variations in the ABCB1 gene.
More... |
All times are GMT -7. The time now is 02:18 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021